• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

胰腺腺癌中、长期幸存者的死因和条件生存估计。

Causes of Death and Conditional Survival Estimates of Medium- and Long-term Survivors of Pancreatic Adenocarcinoma.

机构信息

Department of Surgery, University of Utah, Salt Lake City.

出版信息

JAMA Oncol. 2018 Aug 1;4(8):1129-1130. doi: 10.1001/jamaoncol.2018.2442.

DOI:10.1001/jamaoncol.2018.2442
PMID:30003235
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6584282/
Abstract

This population-based study investigates the survival and causes of death in patients with pancreatic adenocarcinoma to 21 years after diagnosis.

摘要

本基于人群的研究调查了诊断后 21 年内胰腺腺癌患者的生存情况和死亡原因。

相似文献

1
Causes of Death and Conditional Survival Estimates of Medium- and Long-term Survivors of Pancreatic Adenocarcinoma.胰腺腺癌中、长期幸存者的死因和条件生存估计。
JAMA Oncol. 2018 Aug 1;4(8):1129-1130. doi: 10.1001/jamaoncol.2018.2442.
2
Effects of perioperative red blood cell transfusion on disease recurrence and survival after pancreaticoduodenectomy for ductal adenocarcinoma.围手术期红细胞输血对胰十二指肠切除术治疗导管腺癌后疾病复发和生存的影响。
Ann Surg Oncol. 2011 May;18(5):1327-34. doi: 10.1245/s10434-010-1476-3. Epub 2011 Jan 8.
3
Comparison of Demographics, Tumor Characteristics, and Survival Between Pancreatic Adenocarcinomas and Pancreatic Neuroendocrine Tumors: A Population-based Study.胰腺腺癌与胰腺神经内分泌肿瘤的人口统计学、肿瘤特征及生存情况比较：一项基于人群的研究
Am J Clin Oncol. 2018 May;41(5):485-491. doi: 10.1097/COC.0000000000000305.
4
Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma.胰腺侵袭性导管内乳头状黏液性肿瘤：与胰腺导管腺癌的比较
J Surg Oncol. 2009 Jul 1;100(1):13-8. doi: 10.1002/jso.21290.
5
What is the major prognostic factor in tumor-node-metastasis staging of pancreatic adenocarcinoma?胰腺腺癌肿瘤-淋巴结-转移分期中的主要预后因素是什么？
Ann Surg Oncol. 2011 Jan;18(1):300-1. doi: 10.1245/s10434-010-1189-7. Epub 2010 Jun 30.
6
Treatment of Locally Advanced Pancreatic Ductal Adenocarcinoma.局部晚期胰腺导管腺癌的治疗
Adv Surg. 2016 Sep;50(1):115-28. doi: 10.1016/j.yasu.2016.03.010. Epub 2016 Jul 7.
7
Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study.早期疾病进展和手术并发症对可切除性胰腺导管腺癌先行手术患者辅助化疗完成率及生存的影响——一项基于人群的队列研究
Acta Oncol. 2016;55(3):265-77. doi: 10.3109/0284186X.2015.1068445. Epub 2015 Jul 25.
8
Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma.新辅助治疗后中性粒细胞与淋巴细胞比值升高与临界可切除性胰腺导管腺癌切除术后较差的生存率相关。
Surgery. 2016 Nov;160(5):1288-1293. doi: 10.1016/j.surg.2016.04.039. Epub 2016 Jul 20.
9
[Prognosis of pancreatic cancer from histopathological findings].[基于组织病理学结果的胰腺癌预后]
Nihon Rinsho. 2006 Jan;64 Suppl 1:293-6.
10
Prognostic factors for actual long-term survival in the era of multidisciplinary treatment for pancreatic ductal adenocarcinoma.胰腺导管腺癌多学科治疗时代实际长期生存的预后因素。
Langenbecks Arch Surg. 2018 Sep;403(6):693-700. doi: 10.1007/s00423-018-1709-7. Epub 2018 Sep 15.

引用本文的文献

1
Conditional survival analysis and real-time prognosis prediction for prostate cancer patients.前列腺癌患者的条件生存分析与实时预后预测
Sci Rep. 2025 May 28;15(1):18711. doi: 10.1038/s41598-025-00420-9.
2
Conditional Relative Survival of Exocrine Pancreatic Cancer: A Population-Based Study.外分泌胰腺肿瘤的条件性相对生存：一项基于人群的研究。
Ann Surg Oncol. 2024 Feb;31(2):1178-1189. doi: 10.1245/s10434-023-14594-x. Epub 2023 Nov 30.
3
Racial disparities in conditional survival of patients with bladder cancer: a population-based study.膀胱癌患者条件生存的种族差异：一项基于人群的研究。
BMC Urol. 2023 Jul 18;23(1):122. doi: 10.1186/s12894-023-01293-8.
4
Conditional Metastasis of Uveal Melanoma in 8091 Patients over Half-Century (51 Years) by Age Group: Assessing the Entire Population and the Extremes of Age.半个多世纪（51 年）中 8091 例葡萄膜黑色素瘤患者的条件性转移：按年龄组评估整个人群和年龄极值。
Invest Ophthalmol Vis Sci. 2023 Jul 3;64(10):7. doi: 10.1167/iovs.64.10.7.
5
Conditional survival analysis and real-time prognosis prediction for cervical cancer patients below the age of 65 years.65岁以下宫颈癌患者的条件生存分析与实时预后预测
Front Oncol. 2023 Jan 9;12:1049531. doi: 10.3389/fonc.2022.1049531. eCollection 2022.
6
Conditional survival of uveal melanoma using The Cancer Genome Atlas (TCGA) classification (Simplified Version) in 1001 cases.利用癌症基因组图谱（TCGA）分类（简化版）对1001例葡萄膜黑色素瘤进行条件生存分析
Saudi J Ophthalmol. 2021 Nov 17;36(3):308-314. doi: 10.4103/sjopt.sjopt_69_21. eCollection 2022 Jul-Sep.
7
Causes of death and conditional survival estimates of long-term lung cancer survivors.长期肺癌幸存者的死因和条件生存估计。
Front Immunol. 2022 Sep 23;13:1012247. doi: 10.3389/fimmu.2022.1012247. eCollection 2022.
8
Conditional survival of metastatic clear cell renal cell carcinoma: How prognosis evolves after cytoreductive surgery of primary tumor.转移性透明细胞肾细胞癌的条件生存：原发肿瘤细胞减灭术后预后如何演变。
Cancer Med. 2021 Nov;10(21):7492-7502. doi: 10.1002/cam4.4270. Epub 2021 Sep 12.
9
Conditional Survival, Cause-Specific Mortality, and Risk Factors of Late Mortality After Allogeneic Hematopoietic Cell Transplantation.异基因造血细胞移植后条件生存、病因特异性死亡率和晚期死亡率的危险因素。
J Natl Cancer Inst. 2020 Nov 1;112(11):1153-1161. doi: 10.1093/jnci/djaa022.

本文引用的文献

1
Long-term survival in patients with pancreatic ductal adenocarcinoma.胰腺导管腺癌患者的长期生存
Surgery. 2016 Jun;159(6):1520-1527. doi: 10.1016/j.surg.2015.12.024. Epub 2016 Feb 2.
2
Characteristics of 10-Year Survivors of Pancreatic Ductal Adenocarcinoma.胰腺导管腺癌 10 年生存者的特征。
JAMA Surg. 2015 Aug;150(8):701-10. doi: 10.1001/jamasurg.2015.0668.
3
Factors predicting long-term survival following pancreatic resection for ductal adenocarcinoma of the pancreas: 40 years of experience.胰腺导管腺癌胰腺切除术后长期生存的预测因素：40年经验
J Gastrointest Surg. 2014 Apr;18(4):674-81. doi: 10.1007/s11605-013-2408-x. Epub 2013 Nov 16.
4
Pancreatic ductal adenocarcinoma: long-term survival does not equal cure.胰腺导管腺癌：长期生存并不等于治愈。
Surgery. 2012 Sep;152(3 Suppl 1):S43-9. doi: 10.1016/j.surg.2012.05.020. Epub 2012 Jul 3.
5
Clinical calculator of conditional survival estimates for resected and unresected survivors of pancreatic cancer.胰腺癌切除和未切除幸存者条件生存估计的临床计算器。
Arch Surg. 2012 Jun;147(6):513-9. doi: 10.1001/archsurg.2011.2281.
6
Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?胰腺癌胰十二指肠切除术后的长期生存：能否治愈？
Ann Surg. 2008 Mar;247(3):456-62. doi: 10.1097/SLA.0b013e3181613142.